Ribonucleotides

DBCAT000291Pharmacologic class

Nucleotides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed). A DrugBank category of 75 drugs. 10 of them are approved.

Also known as: Phosphates, Ribonucleoside · Ribonucleoside Phosphates
Drugs: (R)-methylmalonyl-CoA
(Rp)-cAMPS
1-(5-phospho-D-ribosyl)-ATP
2'-cytidylic acid
2'-Deoxy-thymidine-beta-L-rhamnose
3-Acetylpyridine Adenine Dinucleotide
3-Hydroxybutyryl-Coenzyme A
3'-Uridinemonophosphate
4-hydroxybenzoyl-CoA
5-methylcytidine 5'-monophosphate
5'-Guanosine-Diphosphate-Monothiophosphate
5'-Guanylylmethylenebisphosphonate
6-aza uridine 5'-monophosphate
6-hydroxy-FAD
7-methyl-5'-guanylic acid
8-oxo-dGMP
Acetoacetyl-CoA
Adenosine 3',5'-diphosphate
Adenosine 5'-[gamma-thio]triphosphate
Adenosine 5'-methylenediphosphate
Adenosine 5'-phosphosulfate
Adenosine disphosphate
Adenosine phosphate
Adenosine Phosphonoacetic Acid
Adenylosuccinic acid
and 50 more with a free account

What you can answer from here — as of August 24, 2016

75DrugsEach linked to its full drug card

566Drug targetsEvery drug–target pair in the class, with bond type

712Marketed productsAcross the regions we cover, with dosage forms and routes

10Routes of administrationHow the drugs in this class are given

Which targets do Ribonucleotides share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account